ERBB2 and breast cancer: Moreover, across both HER2‐negative and ER+ subgroups, we found strong negative correlations between WBC count and VAT SUVmean (Figure 7c,d), reinforcing a potential link between systemic inflammation and suppressed adipose metabolic function in breast cancer across these subtypes.